Institutions / Stonepine Capital Management, LLC
Stonepine Capital Management, LLC
CIK 1440771 · Institution · as of Dec 31, 2025
Portfolio value
$126.43M
Positions
61
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 61 →
| Company | Value | % of portfolio |
|---|---|---|
| Verastem, Inc. | $21.09M | 16.7% |
| ADMA Biologics Inc | $13.50M | 10.7% |
| Evolus, Inc. | $10.85M | 8.6% |
| Zevra Therapeutics, Inc. | $5.10M | 4.0% |
| Inhibikase Therapeutics, Inc. | $4.81M | 3.8% |
| Abeona Therapeutics Inc. | $3.74M | 3.0% |
| Nektar Therapeutics | $3.59M | 2.8% |
| Indivior PLC | $3.59M | 2.8% |
| Corbus Pharmaceuticals Holdings, Inc.CRBP | $3.17M | 2.5% |
| Kazia Therapeutics LtdKZIA | $3.17M | 2.5% |
| XOMA Royalty Corp | $3.06M | 2.4% |
| Verrica Pharmaceuticals Inc.VRCA | $2.94M | 2.3% |
| Cybin Inc. | $2.78M | 2.2% |
| TELA Bio, Inc. | $2.78M | 2.2% |
| ACADIA Pharmaceuticals Inc | $2.67M | 2.1% |
| Surrozen, Inc./DESRZN | $2.57M | 2.0% |
| X4 Pharmaceuticals, Inc | $2.37M | 1.9% |
| Aytu Biopharma Inc | $2.12M | 1.7% |
| Day One Biopharmaceuticals, Inc. | $1.86M | 1.5% |
| Adicet Bio, Inc. | $1.85M | 1.5% |
| Spruce Biosciences, Inc.SPRB | $1.72M | 1.4% |
| Heron Therapeutics, Inc. /De | $1.61M | 1.3% |
| Enanta Pharmaceuticals Inc | $1.58M | 1.2% |
| PMV Pharmaceuticals, Inc.PMVP | $1.44M | 1.1% |
| Camp4 Therapeutics Corp | $1.40M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.